Table 1

Loss of Esterman scores in 27 patients using vigabatrin

ID		Follow up time (months)		Using vigabatrin after surgery	Right eye			Left eye
					Measurement 1				Measurement 2		Measurement 1			Measurement 2
					Temporal						Nasal			Temporal			Nasal		Temporal		Nasal		Temporal		Nasal
					S	I					S	I		S	I		S	I	S	I	S	I	S	I	S	I
1	8.1	no	2	7	1	3	2	5	1	2		2	5	4	8	3	2		2	8
2	6.0	no		6	2	3		7	2	3		4	7		5	3	8			5
3	7.2	no		0	4	4		3	3	3		0	0		5	0	0			5
4	11.2	no		3	1	1		3	1	1		0	2		1	0	1			1
5	26.7	no		0	3	5		2	3	6		0	1		6	0	2			7
6	35.2	no		6	4	4		7	3	4		2	8		6	2	7			7
7	26.4	no		10	4	6		13	4	6		5	12		7	5	12			6
8	11.3	no		7	4	7		7	5	7		3	7		6	3	7			7
9	20.3	no		5	3	5		5	2	3		2	6		6	2	5			5
10	24.9	no		7	3	6		8	2	5		2	4		6	2	4			6
11	31.8	no		7	3	6		8	3	6		3	6		6	2	7			6
12	52.1	no	2	8	5	7	2	7	5	7		2	9	6	7	2	9		6	8
13	28.2	no	3	10		9	4	9		9			12	6	7		9		5	7
14	35.2	no	0	2		2	0	1		2			0	1	0		0		0	1
15	62.4	no	0	0	2	2	0	0	3	0		0	0	2	2	0	0		2	5
16	24.7	no	6	15		14	6	17		14			16	6	11		16		6	12
17	13.4	Yes	1	5	3	6	1	3	3	5		1	5	3	6	1	3		2	6
18	61.4	Yes	2	7	3	7	5	13	4	7		3	6	2	4	5	13		4	6
19	30.5	Yes	6	13	3	7	6	14	3	7		5	14	4	7	6	16		4	7
20	35.0	Yes		0	1	0		0	1	0		0	1		0	0	0			0
21	40.0	Yes		11	3	6		13	3	8		5	12		9	5	14			9
22	41.1	Yes		7	2	5		13	2	7		2	7		3	3	11			5
23	26.8	Yes		13	3	7		16	4	7		2	7		8	4	16			13
24	48.8	Yes	1	4		5	2	6		5			1	2	3		4		2	1
25	28.7	Yes	0	0	2	4	2	5	2	5		0	0	3	4	3	5		3	4
26	35.0	Yes	2	7	2	5	2	7	3	7		2	6	2	2	3	6		2	4
27	24.9	Yes	6	14		8	6	14		7			14	6	9		14		6	10